SLNO logo

Soleno Therapeutics, Inc. (SLNO) Cash and cash equivalents

annual cash & cash equivalents:

$87.93M-$81.75M(-48.18%)
December 31, 2024

Summary

  • As of today (August 21, 2025), SLNO annual cash & cash equivalents is $87.93 million, with the most recent change of -$81.75 million (-48.18%) on December 31, 2024.
  • During the last 3 years, SLNO annual cash & cash equivalents has risen by +$66.62 million (+312.73%).
  • SLNO annual cash & cash equivalents is now -48.18% below its all-time high of $169.68 million, reached on December 31, 2023.

Performance

SLNO Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSLNObalance sheet metrics

quarterly cash & cash equivalents:

$286.84M-$3.11M(-1.07%)
June 30, 2025

Summary

  • As of today (August 21, 2025), SLNO quarterly cash & cash equivalents is $286.84 million, with the most recent change of -$3.11 million (-1.07%) on June 30, 2025.
  • Over the past year, SLNO quarterly cash & cash equivalents has increased by +$20.72 million (+7.79%).
  • SLNO quarterly cash & cash equivalents is now -1.58% below its all-time high of $291.44 million, reached on December 31, 2024.

Performance

SLNO quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSLNObalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

SLNO Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-48.2%+7.8%
3 y3 years+312.7%+1091.9%
5 y5 years+324.1%+358.9%

SLNO Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-48.2%+502.2%-1.6%+3542.9%
5 y5-year-48.2%+502.2%-1.6%+3542.9%
alltimeall time-48.2%+6830.0%-1.6%>+9999.0%

SLNO Cash and cash equivalents History

DateAnnualQuarterly
Jun 2025
-
$286.84M(-1.1%)
Mar 2025
-
$289.95M(-0.5%)
Dec 2024
$87.93M(-48.2%)
$291.44M(+13.5%)
Sep 2024
-
$256.78M(-3.5%)
Jun 2024
-
$266.12M(+77.9%)
Mar 2024
-
$149.63M(-11.8%)
Dec 2023
$169.68M(+1062.0%)
$169.68M(+223.6%)
Sep 2023
-
$52.44M(+170.7%)
Jun 2023
-
$19.37M(+146.0%)
Mar 2023
-
$7.87M(-46.1%)
Dec 2022
$14.60M(-31.5%)
$14.60M(-26.1%)
Sep 2022
-
$19.75M(-17.9%)
Jun 2022
-
$24.07M(-16.9%)
Mar 2022
-
$28.97M(+36.0%)
Dec 2021
$21.30M(-56.7%)
$21.30M(-24.4%)
Sep 2021
-
$28.18M(-16.1%)
Jun 2021
-
$33.60M(-19.3%)
Mar 2021
-
$41.61M(-15.5%)
Dec 2020
$49.22M(+137.4%)
$49.22M(-12.3%)
Sep 2020
-
$56.14M(-10.2%)
Jun 2020
-
$62.50M(+314.7%)
Mar 2020
-
$15.07M(-27.3%)
Dec 2019
$20.73M
$20.73M(+84.7%)
Sep 2019
-
$11.22M(-30.4%)
DateAnnualQuarterly
Jun 2019
-
$16.13M(-20.1%)
Mar 2019
-
$20.19M(-16.1%)
Dec 2018
$23.10M(+35.1%)
$24.08M(+135.1%)
Sep 2018
-
$10.24M(-18.7%)
Jun 2018
-
$12.59M(-15.5%)
Mar 2018
-
$14.90M(-13.0%)
Dec 2017
$17.10M(+527.3%)
$17.14M(+201.6%)
Sep 2017
-
$5.68M(-25.1%)
Jun 2017
-
$7.58M(-28.3%)
Mar 2017
-
$10.57M(+283.0%)
Dec 2016
$2.73M(-50.4%)
$2.76M(-49.3%)
Sep 2016
-
$5.45M(+114.8%)
Jun 2016
-
$2.54M(-61.1%)
Mar 2016
-
$6.53M(+18.0%)
Dec 2015
$5.49M(-30.9%)
$5.53M(+14.5%)
Sep 2015
-
$4.83M(-36.1%)
Jun 2015
-
$7.57M(-20.8%)
Mar 2015
-
$9.55M(+19.7%)
Dec 2014
$7.96M(+527.1%)
$7.98M(+9396.1%)
Sep 2014
-
$84.00K(-93.2%)
Jun 2014
-
$1.23M(+56.6%)
Mar 2014
-
$783.90K(-38.2%)
Dec 2013
$1.27M(-41.1%)
$1.27M
Dec 2012
$2.16M
-

FAQ

  • What is Soleno Therapeutics, Inc. annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Soleno Therapeutics, Inc.?
  • What is Soleno Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
  • What is Soleno Therapeutics, Inc. quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for Soleno Therapeutics, Inc.?
  • What is Soleno Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?

What is Soleno Therapeutics, Inc. annual cash & cash equivalents?

The current annual cash & cash equivalents of SLNO is $87.93M

What is the all time high annual cash & cash equivalents for Soleno Therapeutics, Inc.?

Soleno Therapeutics, Inc. all-time high annual cash & cash equivalents is $169.68M

What is Soleno Therapeutics, Inc. annual cash & cash equivalents year-on-year change?

Over the past year, SLNO annual cash & cash equivalents has changed by -$81.75M (-48.18%)

What is Soleno Therapeutics, Inc. quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of SLNO is $286.84M

What is the all time high quarterly cash & cash equivalents for Soleno Therapeutics, Inc.?

Soleno Therapeutics, Inc. all-time high quarterly cash & cash equivalents is $291.44M

What is Soleno Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?

Over the past year, SLNO quarterly cash & cash equivalents has changed by +$20.72M (+7.79%)
On this page